JW Lifescience Corporation (KRX:234080)

South Korea · Delayed Price · Currency is KRW

13,620

+140 (1.04%)

Feb 20, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceuticals	222.48B	206.86B	188.93B	169.82B	183.52B
Pharmaceuticals Growth	7.55%	9.49%	11.26%	-7.47%	7.81%
Total	222.48B	206.86B	188.93B	169.82B	183.52B
Total Growth	7.55%	9.49%	11.26%	-7.47%	7.81%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Export	13.73B	9.34B	-	-	-
Export Growth	46.98%	-	-	-	-
South Korea	208.69B	197.18B	-	-	-
South Korea Growth	5.84%	-	-	-	-
Unallocated	50.00M	337.14M	-	-	-
Unallocated Growth	-85.17%	-	-	-	-
Total	222.48B	206.86B	-	-	-
Total Growth	7.55%	-	-	-	-

Source: S&P Global Market Intelligence.